3rd Party Medical Device Industry News

Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease

Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory [...]

By |2026-02-10T14:07:35+00:00February 10, 2026|3rd Party Medical Device Industry News|Comments Off on Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease

Study highlights GLP-1 companion effects, underscoring capability of Brightseed’s AI platform to identify and launch clinically-validated, natural health innovations

The study was published in the peer-reviewed journal Bioactive Compounds [...]

By |2026-02-04T16:18:00+00:00February 4, 2026|3rd Party Medical Device Industry News|Comments Off on Study highlights GLP-1 companion effects, underscoring capability of Brightseed’s AI platform to identify and launch clinically-validated, natural health innovations
Go to Top